Cargando…

Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning

INTRODUCTION: Organ-at-risk segmentation for head and neck cancer radiation therapy is a complex and time-consuming process (requiring up to 42 individual structure, and may delay start of treatment or even limit access to function-preserving care. Feasibility of using a deep learning (DL) based aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucido, J. John, DeWees, Todd A., Leavitt, Todd R., Anand, Aman, Beltran, Chris J., Brooke, Mark D., Buroker, Justine R., Foote, Robert L., Foss, Olivia R., Gleason, Angela M., Hodge, Teresa L., Hughes, Cían O., Hunzeker, Ashley E., Laack, Nadia N., Lenz, Tamra K., Livne, Michelle, Morigami, Megumi, Moseley, Douglas J., Undahl, Lisa M., Patel, Yojan, Tryggestad, Erik J., Walker, Megan Z., Zverovitch, Alexei, Patel, Samir H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115982/
https://www.ncbi.nlm.nih.gov/pubmed/37091160
http://dx.doi.org/10.3389/fonc.2023.1137803
_version_ 1785028324216537088
author Lucido, J. John
DeWees, Todd A.
Leavitt, Todd R.
Anand, Aman
Beltran, Chris J.
Brooke, Mark D.
Buroker, Justine R.
Foote, Robert L.
Foss, Olivia R.
Gleason, Angela M.
Hodge, Teresa L.
Hughes, Cían O.
Hunzeker, Ashley E.
Laack, Nadia N.
Lenz, Tamra K.
Livne, Michelle
Morigami, Megumi
Moseley, Douglas J.
Undahl, Lisa M.
Patel, Yojan
Tryggestad, Erik J.
Walker, Megan Z.
Zverovitch, Alexei
Patel, Samir H.
author_facet Lucido, J. John
DeWees, Todd A.
Leavitt, Todd R.
Anand, Aman
Beltran, Chris J.
Brooke, Mark D.
Buroker, Justine R.
Foote, Robert L.
Foss, Olivia R.
Gleason, Angela M.
Hodge, Teresa L.
Hughes, Cían O.
Hunzeker, Ashley E.
Laack, Nadia N.
Lenz, Tamra K.
Livne, Michelle
Morigami, Megumi
Moseley, Douglas J.
Undahl, Lisa M.
Patel, Yojan
Tryggestad, Erik J.
Walker, Megan Z.
Zverovitch, Alexei
Patel, Samir H.
author_sort Lucido, J. John
collection PubMed
description INTRODUCTION: Organ-at-risk segmentation for head and neck cancer radiation therapy is a complex and time-consuming process (requiring up to 42 individual structure, and may delay start of treatment or even limit access to function-preserving care. Feasibility of using a deep learning (DL) based autosegmentation model to reduce contouring time without compromising contour accuracy is assessed through a blinded randomized trial of radiation oncologists (ROs) using retrospective, de-identified patient data. METHODS: Two head and neck expert ROs used dedicated time to create gold standard (GS) contours on computed tomography (CT) images. 445 CTs were used to train a custom 3D U-Net DL model covering 42 organs-at-risk, with an additional 20 CTs were held out for the randomized trial. For each held-out patient dataset, one of the eight participant ROs was randomly allocated to review and revise the contours produced by the DL model, while another reviewed contours produced by a medical dosimetry assistant (MDA), both blinded to their origin. Time required for MDAs and ROs to contour was recorded, and the unrevised DL contours, as well as the RO-revised contours by the MDAs and DL model were compared to the GS for that patient. RESULTS: Mean time for initial MDA contouring was 2.3 hours (range 1.6-3.8 hours) and RO-revision took 1.1 hours (range, 0.4-4.4 hours), compared to 0.7 hours (range 0.1-2.0 hours) for the RO-revisions to DL contours. Total time reduced by 76% (95%-Confidence Interval: 65%-88%) and RO-revision time reduced by 35% (95%-CI,-39%-91%). All geometric and dosimetric metrics computed, agreement with GS was equivalent or significantly greater (p<0.05) for RO-revised DL contours compared to the RO-revised MDA contours, including volumetric Dice similarity coefficient (VDSC), surface DSC, added path length, and the 95%-Hausdorff distance. 32 OARs (76%) had mean VDSC greater than 0.8 for the RO-revised DL contours, compared to 20 (48%) for RO-revised MDA contours, and 34 (81%) for the unrevised DL OARs. CONCLUSION: DL autosegmentation demonstrated significant time-savings for organ-at-risk contouring while improving agreement with the institutional GS, indicating comparable accuracy of DL model. Integration into the clinical practice with a prospective evaluation is currently underway.
format Online
Article
Text
id pubmed-10115982
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101159822023-04-21 Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning Lucido, J. John DeWees, Todd A. Leavitt, Todd R. Anand, Aman Beltran, Chris J. Brooke, Mark D. Buroker, Justine R. Foote, Robert L. Foss, Olivia R. Gleason, Angela M. Hodge, Teresa L. Hughes, Cían O. Hunzeker, Ashley E. Laack, Nadia N. Lenz, Tamra K. Livne, Michelle Morigami, Megumi Moseley, Douglas J. Undahl, Lisa M. Patel, Yojan Tryggestad, Erik J. Walker, Megan Z. Zverovitch, Alexei Patel, Samir H. Front Oncol Oncology INTRODUCTION: Organ-at-risk segmentation for head and neck cancer radiation therapy is a complex and time-consuming process (requiring up to 42 individual structure, and may delay start of treatment or even limit access to function-preserving care. Feasibility of using a deep learning (DL) based autosegmentation model to reduce contouring time without compromising contour accuracy is assessed through a blinded randomized trial of radiation oncologists (ROs) using retrospective, de-identified patient data. METHODS: Two head and neck expert ROs used dedicated time to create gold standard (GS) contours on computed tomography (CT) images. 445 CTs were used to train a custom 3D U-Net DL model covering 42 organs-at-risk, with an additional 20 CTs were held out for the randomized trial. For each held-out patient dataset, one of the eight participant ROs was randomly allocated to review and revise the contours produced by the DL model, while another reviewed contours produced by a medical dosimetry assistant (MDA), both blinded to their origin. Time required for MDAs and ROs to contour was recorded, and the unrevised DL contours, as well as the RO-revised contours by the MDAs and DL model were compared to the GS for that patient. RESULTS: Mean time for initial MDA contouring was 2.3 hours (range 1.6-3.8 hours) and RO-revision took 1.1 hours (range, 0.4-4.4 hours), compared to 0.7 hours (range 0.1-2.0 hours) for the RO-revisions to DL contours. Total time reduced by 76% (95%-Confidence Interval: 65%-88%) and RO-revision time reduced by 35% (95%-CI,-39%-91%). All geometric and dosimetric metrics computed, agreement with GS was equivalent or significantly greater (p<0.05) for RO-revised DL contours compared to the RO-revised MDA contours, including volumetric Dice similarity coefficient (VDSC), surface DSC, added path length, and the 95%-Hausdorff distance. 32 OARs (76%) had mean VDSC greater than 0.8 for the RO-revised DL contours, compared to 20 (48%) for RO-revised MDA contours, and 34 (81%) for the unrevised DL OARs. CONCLUSION: DL autosegmentation demonstrated significant time-savings for organ-at-risk contouring while improving agreement with the institutional GS, indicating comparable accuracy of DL model. Integration into the clinical practice with a prospective evaluation is currently underway. Frontiers Media S.A. 2023-04-06 /pmc/articles/PMC10115982/ /pubmed/37091160 http://dx.doi.org/10.3389/fonc.2023.1137803 Text en Copyright © 2023 Lucido, DeWees, Leavitt, Anand, Beltran, Brooke, Buroker, Foote, Foss, Gleason, Hodge, Hughes, Hunzeker, Laack, Lenz, Livne, Morigami, Moseley, Undahl, Patel, Tryggestad, Walker, Zverovitch and Patel https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Lucido, J. John
DeWees, Todd A.
Leavitt, Todd R.
Anand, Aman
Beltran, Chris J.
Brooke, Mark D.
Buroker, Justine R.
Foote, Robert L.
Foss, Olivia R.
Gleason, Angela M.
Hodge, Teresa L.
Hughes, Cían O.
Hunzeker, Ashley E.
Laack, Nadia N.
Lenz, Tamra K.
Livne, Michelle
Morigami, Megumi
Moseley, Douglas J.
Undahl, Lisa M.
Patel, Yojan
Tryggestad, Erik J.
Walker, Megan Z.
Zverovitch, Alexei
Patel, Samir H.
Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
title Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
title_full Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
title_fullStr Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
title_full_unstemmed Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
title_short Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
title_sort validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115982/
https://www.ncbi.nlm.nih.gov/pubmed/37091160
http://dx.doi.org/10.3389/fonc.2023.1137803
work_keys_str_mv AT lucidojjohn validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT deweestodda validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT leavitttoddr validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT anandaman validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT beltranchrisj validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT brookemarkd validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT burokerjustiner validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT footerobertl validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT fossoliviar validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT gleasonangelam validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT hodgeteresal validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT hughesciano validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT hunzekerashleye validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT laacknadian validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT lenztamrak validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT livnemichelle validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT morigamimegumi validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT moseleydouglasj validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT undahllisam validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT patelyojan validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT tryggestaderikj validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT walkermeganz validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT zverovitchalexei validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning
AT patelsamirh validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning